Intravenous transplantation of BMP2-transduced endothelial progenitor cells attenuates lipopolysaccharide-induced acute lung injury in rats

Cellular Physiology and Biochemistry

Volumn 35, Issue 6, 2015, Pages 2149-2158

  Yin, Xiuru ^a   Liang, Zuodi ^a   Yun, Yue ^a   Pei, Ling ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Bone morphogenetic protein; Endothelial progenitor cells; Gene therapy; Lipopolysaccharide

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LENTIVIRUS VECTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; BMP2 PROTEIN, RAT;

ACUTE LUNG INJURY; ADHERENT CELL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BONE MARROW DERIVED ENDOTHELIAL PROGENITOR CELL TRANSPLANTATION; CAPILLARY PERMEABILITY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM; INFLAMMATION; JUGULAR VEIN; LUNG FLUID; LUNG LAVAGE; LUNG WEIGHT; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; RAT; STEM CELL TRANSPLANTATION; TRACHEA; VIRAL GENE THERAPY; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ACUTE LUNG INJURY; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; DISEASE MODELS, ANIMAL; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; MALE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84928136756     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374020     Document Type: Article

References (35)

1. Frutos-Vivar F, Nin N, Esteban A: Epidemiology of acute lung injury and acute respiratory distress syndrome. Curr Opin Crit Care 2004;10:1-6.
2. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
4. Lam CF, Liu YC, Hsu JK, Yeh PA, Su TY, Huang CC, Lin MW, Wu PC, Chang PJ, Tsai YC: Autologous transplantation of endothelial progenitor cells attenuates acute lung injury in rabbits. Anesthesiology 2008;108:392-401.
5. Mao M, Wang SN, Lv XJ, Wang Y, Xu JC: Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats. Shock 2010;34:196-204.
6. Lam CF, Roan JN, Lee CH, Chang PJ, Huang CC, Liu YC, Jiang MJ, Tsai YC: Transplantation of endothelial progenitor cells improves pulmonary endothelial function and gas exchange in rabbits with endotoxininduced acute lung injury. Anesth Analg 2011;112:620-627.
7. Cao JP, He XY, Xu HT, Zou Z, Shi XY: Autologous transplantation of peripheral blood-derived circulating endothelial progenitor cells attenuates endotoxin-induced acute lung injury in rabbits by direct endothelial repair and indirect immunomodulation. Anesthesiology 2012;116:1278-1287.
8. Gao X, Chen W, Liang Z, Chen L: Autotransplantation of circulating endothelial progenitor cells protects against lipopolysaccharide-induced acute lung injury in rabbit. Int Immunopharmacol 2011;11:1584-1590.
9. Rabelink TJ, de Boer HC, de Koning EJ, van Zonneveld AJ: Endothelial progenitor cells: More than an inflammatory response? Arterioscler Thromb Vasc Biol 2004;24:834-838.
10. Zhang Y, Ingram DA, Murphy MP, Saadatzadeh MR, Mead LE, Prater DN, Rehman J: Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2009;296:H1675-1682.
11. Hur J, Yoon CH, Lee CS, Kim TY, Oh IY, Park KW, Kim JH, Lee HS, Kang HJ, Chae IH, Oh BH, Park YB, Kim HS: Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 2007;25:1769-1778.
12. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-738.
13. Park SJ, Baek SH, Oh MK, Choi SH, Park EH, Kim NH, Shin JC, Kim IS: Enhancement of angiogenic and vasculogenic potential of endothelial progenitor cells by haptoglobin. FEBS Lett 2009;583:3235-3240.
14. Kuliszewski MA, Kobulnik J, Lindner JR, Stewart DJ, Leong-Poi H: Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. Mol Ther 2011;19:895-902.
15. Chen L, Wu F, Xia WH, Zhang YY, Xu SY, Cheng F, Liu X, Zhang XY, Wang SM, Tao J: CXCR4 gene transfer contributes to in vivo reendothelialization capacity of endothelial progenitor cells. Cardiovasc Res 2010;88:462-470.
16. Song MB, Yu XJ, Zhu GX, Chen JF, Zhao G, Huang L: Transfection of hgf gene enhances endothelial progenitor cell (epc) function and improves epc transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats. Vascul Pharmacol 2009;51:205-213.
17. Zhao Q, Liu Z, Wang Z, Yang C, Liu J, Lu J: Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension. Ann Thorac Surg 2007;84:544-552.
18. Nagaya N, Kangawa K, Kanda M, Uematsu M, Horio T, Fukuyama N, Hino J, Harada-Shiba M, Okumura H, Tabata Y, Mochizuki N, Chiba Y, Nishioka K, Miyatake K, Asahara T, Hara H, Mori H: Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003;108:889-895.
19. Belmokhtar K, Bourguignon T, Worou ME, Khamis G, Bonnet P, Domenech J, Eder V: Regeneration of three layers vascular wall by using BMP2-treated MSC involving HIF-1α and Id1 expressions through JAK/STAT pathways. Stem Cell Rev 2011;7:847-859.
20. Raida M, Heymann AC, Gunther C, Niederwieser D: Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 2006;18:735-739.
21. Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, Stewart DJ: Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006;98:209-217.
22. Burton VJ, Ciuclan LI, Holmes AM, Rodman DM, Walker C, Budd DC: Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function. Blood 2011;117:333-341.
23. Li H, Qiang Y, Wang L, Wang G, Yi J, Jing H, Wu H: Repair of lipopolysaccharide-induced acute lung injury in mice by endothelial progenitor cells, alone and in combination with simvastatin. Chest 2013;144:876-886
24. Fadini GP, Agostini C, Avogaro A: Characterization of endothelial progenitor cells. Biochem Biophys Res Commun 2005;336:1-2.
25. Tomashefski JF, Jr.: Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000;21:435-466.
26. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, Suzuki T, Sasaki H: Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 2004;172:1266-1272.
27. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B: Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007;27:1572-1579.
28. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB: Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-293.
29. Zampetaki A, Kirton JP, Xu Q: Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008;78:413-421.
30. ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ: Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 2003;211:105-113.
31. Picanco-Castro V, de Sousa Russo-Carbolante EM, Tadeu Covas D: Advances in lentiviral vectors: a patent review. Recent Pat DNA Gene Seq 2012;6:82-90.
32. Gangopahyay A, Oran M, Bauer EM, Wertz JW, Comhair SA, Erzurum SC, Bauer PM: Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation. J Biol Chem 2011;286:33134-33140.
33. Anderson L, Lowery JW, Frank DB, Novitskaya T, Jones M, Mortlock DP, Chandler RL, de Caestecker MP: Bmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol 2010;298:R833-842.
34. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9:1370-1376.
35. Hatakeyama T, Pappas PJ, Hobson RW, 2nd, Boric MP, Sessa WC, Duran WN: Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol 2006;574:275-281.